116 related articles for article (PubMed ID: 22143926)
21. Hepatic adenoma in a 7-year-old girl: a case report and literature review.
Gao Y; Zhou J; Xie YC; Qiu LJ; Duan L; A ZX; Wu HF; Lv MX
BMC Pediatr; 2023 Aug; 23(1):420. PubMed ID: 37620840
[TBL] [Abstract][Full Text] [Related]
22. Diffusion-weighted imaging of the liver: an update.
Bharwani N; Koh DM
Cancer Imaging; 2013 Apr; 13(2):171-85. PubMed ID: 23598460
[TBL] [Abstract][Full Text] [Related]
23. Differentiation between small hepatocellular carcinoma (<3 cm) and benign hepatocellular lesions in patients with Budd-Chiari syndrome: the role of multiparametric MR imaging.
Zandieh G; Shahbazian H; Tang H; Wu Q; Shaghaghi M; Hazhirkarzar B; Baghdadi A; Afyouni S; Verde F; Pawlik T; Kamel I
Front Oncol; 2023; 13():1282181. PubMed ID: 38074677
[TBL] [Abstract][Full Text] [Related]
24. Beta-Catenin-Mutated Hepatocellular Adenomas at Hepatobiliary Phase MRI: A Systematic Review and Meta-Analysis.
Shen L; Altmayer S; Tse JR
J Magn Reson Imaging; 2024 Feb; ():. PubMed ID: 38465878
[TBL] [Abstract][Full Text] [Related]
25. Paediatric hepatocellular adenomas: Lessons from a systematic review of relevant literature.
Scheers I; Tambucci R; De Magnee C; Pire A; Stephenne X; Reding R; Nault JC
JHEP Rep; 2024 Jun; 6(6):101078. PubMed ID: 38699071
[TBL] [Abstract][Full Text] [Related]
26. Pediatric Hepatocellular Adenomas: What Is Known and What Is New?
Espinoza AF; Vasudevan SA; Masand PM; Lòpez-Terrada DH; Patel KR
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835484
[TBL] [Abstract][Full Text] [Related]
27. Hepatocellular adenomas (HCAs) and pregnancy.
Guy J
Clin Liver Dis (Hoboken); 2024; 23(1):e0103. PubMed ID: 38312995
[No Abstract] [Full Text] [Related]
28. Focal nodular hyperplasia of the liver: diffusion and perfusion MRI characteristics.
Donati F; Boraschi P; Gigoni R; Salemi S; Falaschi F; Bartolozzi C
Magn Reson Imaging; 2013 Jan; 31(1):10-6. PubMed ID: 22898696
[TBL] [Abstract][Full Text] [Related]
29. Intravoxel incoherent motion diffusion-weighted imaging for characterizing focal hepatic lesions: Correlation with lesion enhancement.
Choi IY; Lee SS; Sung YS; Cheong H; Lee H; Byun JH; Kim SY; Lee SJ; Shin YM; Lee MG
J Magn Reson Imaging; 2017 Jun; 45(6):1589-1598. PubMed ID: 27664970
[TBL] [Abstract][Full Text] [Related]
30. Comparison of magnetic resonance elastography and diffusion-weighted imaging for differentiating benign and malignant liver lesions.
Hennedige TP; Hallinan JT; Leung FP; Teo LL; Iyer S; Wang G; Chang S; Madhavan KK; Wee A; Venkatesh SK
Eur Radiol; 2016 Feb; 26(2):398-406. PubMed ID: 26032879
[TBL] [Abstract][Full Text] [Related]
31. 3D variable flip angle T1 mapping for differentiating benign and malignant liver lesions at 3T: comparison with diffusion weighted imaging.
Wang F; Yang Q; Zhang Y; Liu J; Liu M; Zhu J
BMC Med Imaging; 2022 Aug; 22(1):146. PubMed ID: 35982406
[TBL] [Abstract][Full Text] [Related]
32. Benign focal liver lesions: The role of magnetic resonance imaging.
Gatti M; Maino C; Tore D; Carisio A; Darvizeh F; Tricarico E; Inchingolo R; Ippolito D; Faletti R
World J Hepatol; 2022 May; 14(5):923-943. PubMed ID: 35721295
[TBL] [Abstract][Full Text] [Related]
33. Overcoming differential tumor penetration of BRAF inhibitors using computationally guided combination therapy.
Ng TSC; Hu H; Kronister S; Lee C; Li R; Gerosa L; Stopka SA; Burgenske DM; Khurana I; Regan MS; Vallabhaneni S; Putta N; Scott E; Matvey D; Giobbie-Hurder A; Kohler RH; Sarkaria JN; Parangi S; Sorger PK; Agar NYR; Jacene HA; Sullivan RJ; Buchbinder E; Mikula H; Weissleder R; Miller MA
Sci Adv; 2022 Apr; 8(17):eabl6339. PubMed ID: 35486732
[TBL] [Abstract][Full Text] [Related]
34. Quantitative magnetic resonance imaging for focal liver lesions: bridging the gap between research and clinical practice.
Cannella R; Sartoris R; Grégory J; Garzelli L; Vilgrain V; Ronot M; Dioguardi Burgio M
Br J Radiol; 2021 Jun; 94(1122):20210220. PubMed ID: 33989042
[TBL] [Abstract][Full Text] [Related]
35. R2* value derived from multi-echo Dixon technique can aid discrimination between benign and malignant focal liver lesions.
Shi GZ; Chen H; Zeng WK; Gao M; Wang MZ; Zhang HT; Shen J
World J Gastroenterol; 2021 Mar; 27(12):1182-1193. PubMed ID: 33828393
[TBL] [Abstract][Full Text] [Related]
36. Diffusion-weighted imaging with background body signal suppression (DWIBS) distinguishes benign lesions from malignant pulmonary solitary lesions.
Zhao C; Deng D; Ye W; Long L; Lu Y; Wei Y
Am J Transl Res; 2021; 13(1):88-101. PubMed ID: 33527010
[TBL] [Abstract][Full Text] [Related]
37. Diffusion Kurtosis MR Imaging versus Conventional Diffusion-Weighted Imaging for Distinguishing Hepatocellular Carcinoma from Benign Hepatic Nodules.
Jia Y; Cai H; Wang M; Luo Y; Xu L; Dong Z; Yan X; Li ZP; Feng ST
Contrast Media Mol Imaging; 2019; 2019():2030147. PubMed ID: 31396023
[TBL] [Abstract][Full Text] [Related]
38. Atypical Appearance of Hepatocellular Carcinoma and Its Mimickers: How to Solve Challenging Cases Using Gadoxetic Acid-Enhanced Liver Magnetic Resonance Imaging.
Kim JH; Joo I; Lee JM
Korean J Radiol; 2019 Jul; 20(7):1019-1041. PubMed ID: 31270973
[TBL] [Abstract][Full Text] [Related]
39. Hepatocellular Carcinoma: State of the Art Imaging and Recent Advances.
Navin PJ; Venkatesh SK
J Clin Transl Hepatol; 2019 Mar; 7(1):72-85. PubMed ID: 30944823
[TBL] [Abstract][Full Text] [Related]
40. New MRI features improve subtype classification of hepatocellular adenoma.
Bise S; Frulio N; Hocquelet A; Alberti N; Blanc JF; Laurent C; Laumonier H; Balabaud C; Bioulac-Sage P; Trillaud H
Eur Radiol; 2019 May; 29(5):2436-2447. PubMed ID: 30523457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
